Takeda Rises After AI-Developed Psoriasis Pill Trial Success
Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition.
Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
